HPA Axis Study in Adults

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

A multicenter, open-label study to evaluate the adrenal suppression potential of Mapracorat 0.1% ointment in adults with atopic dermatitis.

Phase 2

Bayer